These compounds, Abacavir Sulfate, Abarelix, and Abiraterone Acetate, each possess unique chemical structures leading to their varying pharmacological effects. Abacavir Sulfate, a nucleoside reverse transcriptase inhibitor, is readily recognized via its molecular formula – C14H15N6O4·H2SO4 – and characteristic spectral properties observed in techniques such as mass spectrometry and infrared spectroscopy. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor inhibitor, presents with a complex peptide sequence, typically requiring amino acid sequencing and peptide mapping for total identification. Finally, Abiraterone Acetate, a CYP17 inhibitor utilized in prostate cancer treatment, can be verified through its precise mass and fragmentation patterns acquired through gas chromatography-mass spectrometry (GC-MS) alongside nuclear magnetic resonance (NMR) analytical data, ensuring its correct chemical characterization.
Catalogue: Abacavir Sulfate Sulfate (CAS 188062-50-2) & Related Compounds
Explore a extensive listing detailing Abacavir Disulfate Sulfate, identified by CAS number 188062-50-2, and a range of related substances. We supply includes multiple levels to fulfill specific research and manufacturing requirements. Discover detailed information including chemical information and stock containers options. Additionally, review our selection of structurally similar materials that could be helpful in the latest initiative. The listing is structured to assist streamlined sourcing of pure chemical materials.
Pharmaceutical Listing: Abarelex and Abirateronum Acetate Registry Identifiers
For scientists and drug professionals needing precise chemical identification, precise CAS identifiers are vital. Specifically, abarelix, a hormone-releasing hormone modulator used in managing prostate tumors, is assigned the CAS identifier 65572-21-8. Furthermore, abiraterone acetate, a significant medication in prostate disease, carries the Chemical Abstract Service number 389292-17-3. Thorough recording and validation of these Registry identifiers are critical to ensure accurate compound identification and related procedures. Such identifiers are publicly obtainable through various chemical resources. Always consult authorized data for the current data.
Pharmaceutical Components: Abacavir Sulfate, , Abiraterone Acetate, Registry Numbers
The identification of key pharmaceutical components often relies on precise chemical identifiers. Notably, this section quickly addresses three notable cases: Abacavir Sulfate, AILAMODE 123663-49-0 a nucleoside reverse transcriptase inhibitor; , a gonadotropin-releasing antagonist; and Abiraterone Acetate, utilized in cancer therapy. These substance is connected with a unique Chemical Abstracts Service number, supplying a universal method for tracking details and guaranteeing accurate communication within the research industry. Consult the respective resources for detailed entries and related data.
CAS Registry Number Database: Information for Abacavir Sulfate, Abarelix, Abiraterone Acetate
The comprehensive Chemical Abstracts Service (CAS) number is an invaluable resource for chemists and manufacturing professionals alike. This section briefly outlines information pertaining to three key therapeutic compounds: Abacavir Sulfate, a drug used to treat HIV; Abarelix Acetate, a antagonist utilized in therapy; and Abiraterone Acetate, a powerful medication applied in the management of metastatic prostate cancer. Finding the accurate CAS identification for each substance allows for certain identification and facilitates precise research searching. These individual identifiers are necessary for data validation and uniform documentation across the field.
Leveraging API Material Data: Item Determination with Chemical Abstracts Service Numbers
Accurate compound recognition is critical in the chemical industry, and Web API material data provides a consistent answer. Specifically, Chemical Abstracts Service numbers act as unique codes for material entities, enabling effortless integration with repositories and systems. This technique furthermore bolsters data precision but also streamlines workflows related to research, acquisition, and compliance documentation. Moreover, obtaining this data via an Application Programming Interface supports automation and reduces the chance for operator mistake.